Uncategorized
VIDEO: M22 intense pulsed light treatment improves meibomian gland function, tear breakup time
NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Sheila C. Barbarino, MD, discusses ongoing study results of the M22 intense pulsed light from Lumenis for treating meibomian gland disease.